LATE-BREAKING ABSTRACT: Induction of granulocyte apoptosis by Bcl-2 inhibitors reduces steroid-insensitive airway inflammation Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8 Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016
Andrographolide restores steroid sensitivity to block LPS/IFN-γ-induced IL-27 and airway hyperresponsiveness in mice Source: International Congress 2015 – New models for treating airway diseases Year: 2015
Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
The immunomodulatory activity of protein S protects against allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
Osteopontin binds and modulate the antibacterial action of eosinophil-recruiting chemokines during allergic inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014
cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Low level laser in monotherapy or in combination with leukotriene receptor antagonists in the treatment of allergic lung inflammation Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015
Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015
PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
ARRY-502, a potent, selective, oral CRTh2 antagonist reduces Th2 mediators in patients with mild to moderate Th2-driven asthma Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016